Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease

Overview

Journal Curr Environ Health Rep

Specialty Environmental Health

Date 2016 Feb 10

PMID 26857251

Citations 66

Authors

Beate R Ritz

Kimberly C Paul

Jeff M Bronstein

Affiliations

Soon will be listed here.

Abstract

At the start of the postgenomics era, most Parkinson's disease (PD) etiology cannot be explained by our knowledge of genetic or environmental factors alone. For more than a decade, we have explored gene-environment (GxE) interactions possibly responsible for the heterogeneity of genetic as well as environmental results across populations. We developed three pesticide exposure measures (ambient due to agricultural applications, home and garden use, and occupational use) in a large population-based case-control study of incident PD in central California. Specifically, we assessed interactions with genes responsible for pesticide metabolism (PON1); transport across the blood-brain barrier (ABCB1); pesticides interfering with or depending on dopamine transporter activity (DAT/SLC6A3) and dopamine metabolism (ALDH2); impacting mitochondrial function via oxidative/nitrosative stress (NOS1) or proteasome inhibition (SKP1); and contributing to immune dysregulation (HLA-DR). These studies established some specificity for pesticides' neurodegenerative actions, contributed biologic plausibility to epidemiologic findings, and identified genetically susceptible populations.

Citing Articles

Lewy body diseases and the gut.

Sampson T, Tansey M, West A, Liddle R Mol Neurodegener. 2025; 20(1):14.

PMID: 39885558 PMC: 11783828. DOI: 10.1186/s13024-025-00804-5.

Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.

Atterling Brolin K, Schaeffer E, Kuri A, Rumrich I, Schumacher Schuh A, Darweesh S Mov Disord. 2024; 40(2):204-221.

PMID: 39601461 PMC: 11832802. DOI: 10.1002/mds.30067.

Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L Neurotoxicology. 2024; 103:266-287.

PMID: 38964509 PMC: 11288778. DOI: 10.1016/j.neuro.2024.06.016.

Genome-wide meta-analysis of short-tandem repeats for Parkinson's disease risk using genotype imputation.

Ohlei O, Paul K, Searles Nielsen S, Gmelin D, Dobricic V, Altmann V Brain Commun. 2024; 6(3):fcae146.

PMID: 38863574 PMC: 11166220. DOI: 10.1093/braincomms/fcae146.

Untargeted serum metabolic profiling of diabetes mellitus among Parkinson's disease patients.

Li S, Lin Y, Jones D, Walker D, Folle A, Del Rosario I NPJ Parkinsons Dis. 2024; 10(1):100.

PMID: 38730245 PMC: 11087477. DOI: 10.1038/s41531-024-00711-4.

References

Liu Y, Yang J, Zheng J, Liu D, Liu T, Wang J . Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis. Gene. 2012; 501(2):188-92. DOI: 10.1016/j.gene.2012.03.067. View

Rappold P, Cui M, Chesser A, Tibbett J, Grima J, Duan L . Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc Natl Acad Sci U S A. 2011; 108(51):20766-71. PMC: 3251116. DOI: 10.1073/pnas.1115141108. View

Richter R, Jarvik G, Furlong C . Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol. 2008; 235(1):1-9. PMC: 3045428. DOI: 10.1016/j.taap.2008.11.001. View

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper J . SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 1996; 86(2):263-74. DOI: 10.1016/s0092-8674(00)80098-7. View

Yoshii S, Kishi C, Ishihara N, Mizushima N . Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem. 2011; 286(22):19630-40. PMC: 3103342. DOI: 10.1074/jbc.M110.209338. View

Wang A, Cockburn M, Ly T, Bronstein J, Ritz B . The association between ambient exposure to organophosphates and Parkinson's disease risk. Occup Environ Med. 2014; 71(4):275-81. PMC: 4351788. DOI: 10.1136/oemed-2013-101394. View

Kelada S, Costa-Mallen P, Checkoway H, Carlson C, Weller T, Swanson P . Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics. 2005; 15(9):659-68. DOI: 10.1097/01.fpc.0000170917.04275.d6. View

Quadri M, Yang X, Cossu G, Olgiati S, Saddi V, Breedveld G . An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate. Neurogenetics. 2014; 16(1):55-64. DOI: 10.1007/s10048-014-0425-x. View

Barbeau A, DALLAIRE L, Buu N, Poirier J, RUCINSKA E . Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci. 1985; 37(16):1529-38. DOI: 10.1016/0024-3205(85)90185-7. View

10.

Martinez T, Greenamyre J . Toxin models of mitochondrial dysfunction in Parkinson's disease. Antioxid Redox Signal. 2011; 16(9):920-34. PMC: 3292753. DOI: 10.1089/ars.2011.4033. View

11.

Taylor M, Le Couteur D, Mellick G, Board P . Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population. J Neural Transm (Vienna). 2000; 107(8-9):979-83. DOI: 10.1007/s007020070046. View

12.

Shimizu K, Matsubara K, Ohtaki K, Shiono H . Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci Res. 2003; 46(4):523-32. DOI: 10.1016/s0168-0102(03)00163-9. View

13.

Ebrahimi-Fakhari D, Wahlster L, McLean P . Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol. 2012; 124(2):153-72. PMC: 3417142. DOI: 10.1007/s00401-012-1004-6. View

14.

Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, OSullivan G, Pal A . Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012; 2:898. PMC: 3510466. DOI: 10.1038/srep00898. View

15.

Teschke K, Chow Y, Bartlett K, Ross A, van Netten C . Spatial and temporal distribution of airborne Bacillus thuringiensis var. kurstaki during an aerial spray program for gypsy moth eradication. Environ Health Perspect. 2001; 109(1):47-54. PMC: 1242050. DOI: 10.1289/ehp.0110947. View

16.

Glotfelty D, Seiber J, Liljedahl L . Pesticides in fog. Nature. 1987; 325(6105):602-5. DOI: 10.1038/325602a0. View

17.

Kavya R, Saluja R, Singh S, Dikshit M . Nitric oxide synthase regulation and diversity: implications in Parkinson's disease. Nitric Oxide. 2006; 15(4):280-94. DOI: 10.1016/j.niox.2006.07.003. View

18.

Przedborski S, Ischiropoulos H . Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid Redox Signal. 2005; 7(5-6):685-93. DOI: 10.1089/ars.2005.7.685. View

19.

Trinh J, Farrer M . Advances in the genetics of Parkinson disease. Nat Rev Neurol. 2013; 9(8):445-54. DOI: 10.1038/nrneurol.2013.132. View

20.

Liew Z, Wang A, Bronstein J, Ritz B . Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease. Arch Environ Occup Health. 2014; 69(4):241-51. PMC: 3916959. DOI: 10.1080/19338244.2013.778808. View